Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of central nervous system (CNS) agents. Its structure supports the creation of bioactive molecules with potential antipsychotic, antidepressant, or anxiolytic properties. Commonly employed in medicinal chemistry research for modifying piperazine-based drug candidates to enhance selectivity, metabolic stability, and receptor binding affinity. Also utilized in the preparation of analogs for structure-activity relationship (SAR) studies.